Dr Hsieh Wen-Son


BS Neuroscience (Tulane), MD (Johns Hopkins), Internal Medicine (Duke), Medical Oncology (Johns Hopkins), Diplomate Internal Medicine and Medical Oncology ABIM (USA).

Dr Wen-Son Hsieh is specialist in medical oncology. He treats various cancers and is active in developing molecularly targeted anti-cancer treatments. After studying philosophy and psychology at Oxford University on a Rhodes Scholarship, Dr Hsieh completed his medical training at Johns Hopkins and Duke Universities. After completion of his training in internal medicine and medical oncology, Dr Hsieh was actively involved in patient care, teaching, and research as a full time faculty member at the Johns Hopkins University School of Medicine, with a primary appointment in the division of haematologic malignancies. He remains a part time Assistant Professor at Johns Hopkins University and is a Principal Associate in the Cancer Sciences Institute of Singapore at the National University of Singapore, where he is involved in the development of novel tests to diagnose cancer and novel treatments for cancer.

With a research interest in molecularly targeted cancer therapies, immunotherapy and molecular diagnostics, Dr Hsieh has led a number of international studies involving centres in Singapore, Hong Kong, Korea, the Philippines, Myanmar and the United States. These studies examined novel treatments and diagnostic tests for nasopharyngeal and hepatocellular carcinomas. He is currently the principal investigator of more than ten active clinical trials, has authored over 80 scientific articles, abstracts, and book chapter, and had lectured at regional and international medical conferences. Dr Hsieh is committed to providing evidence-based treatment for cancer patients as well as to developing more effective cancer treatments.

His specialty interests are haematological malignancies, including lymphomas, head and neck cancers and hepatobiliary cancers.